PERUTELLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 300
EU - Europa 129
AS - Asia 75
AF - Africa 2
SA - Sud America 1
Totale 507
Nazione #
US - Stati Uniti d'America 298
IT - Italia 39
IE - Irlanda 38
CN - Cina 33
SE - Svezia 26
SG - Singapore 22
UA - Ucraina 9
IN - India 6
HK - Hong Kong 5
FR - Francia 4
PL - Polonia 4
BY - Bielorussia 3
KR - Corea 3
CA - Canada 2
NG - Nigeria 2
RO - Romania 2
VN - Vietnam 2
AR - Argentina 1
BE - Belgio 1
FI - Finlandia 1
GB - Regno Unito 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
TR - Turchia 1
Totale 507
Città #
Chandler 76
Dublin 38
Singapore 18
Fairfield 14
Nyköping 14
Ashburn 13
Houston 9
Beijing 8
Hangzhou 8
New York 8
Princeton 8
Guangzhou 7
Medford 7
Ann Arbor 6
Torino 6
Chennai 5
Seattle 5
Turin 5
Bologna 4
Boston 4
Cambridge 4
Canelli 4
Guiyang 4
Hong Kong 4
San Mateo 4
Warsaw 4
Wilmington 4
Redwood City 3
San Diego 3
Seoul 3
Abuja 2
Fremont 2
Hebei 2
Los Angeles 2
Nanjing 2
Naples 2
Norwalk 2
Rome 2
Upper Marlboro 2
Washington 2
Aiello Del Sabato 1
Brussels 1
Buenos Aires 1
Chengdu 1
Chicago 1
Droitwich 1
East Brunswick 1
Fort Collins 1
Grugliasco 1
Izmir 1
Jacksonville 1
Lappeenranta 1
Milan 1
Montreal 1
Pune 1
Santa Clara 1
Toronto 1
Venezia 1
Woodbridge 1
Totale 339
Nome #
Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 84
Real life use of bendamustine in elderly patients with lymphoid neoplasia 81
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll 60
Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib 58
Cd200 baseline serum levels predict prognosis of chronic lymphocytic leukemia 57
Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia 50
Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia 47
Immunotherapeutic strategies in chronic lymphocytic leukemia: advances and challenges 38
Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia 20
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia 14
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 11
CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep? 9
Totale 529
Categoria #
all - tutte 2.392
article - articoli 0
book - libri 0
conference - conferenze 219
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.611


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202177 0 0 0 4 13 3 9 6 12 2 1 27
2021/2022142 8 7 14 7 11 2 10 4 5 13 34 27
2022/2023189 20 19 2 15 15 49 14 12 24 5 5 9
2023/2024101 13 17 7 4 3 25 0 6 1 7 7 11
2024/202520 4 13 3 0 0 0 0 0 0 0 0 0
Totale 529